Skip to main content

Table 1 Demographic characteristics and CMR results in participants

From: Comparison of different cardiovascular magnetic resonance sequences for native myocardial T1 mapping at 3T

Variables

Healthy

Low added risk

Moderate added risk

Sig

(n = 9)

(n = 18)

(n = 13)

(p value)

Age (years)

58.4 ± 11.1

59.2 ± 5.4

58.2 ± 5.7

0.93

Male gender (%)

33.3

44.4

53.8

0.64

Diabetes M. (%)

0

0

15.4

0.11

Dyslipidemia (%)

0

11.1

61.5

< .01

Obesity (%)

0

27.8

23.1

0.22

Current smoker (%)

0

11.1

0

0.57

Sedentary (%)

0

0

0

FH CVD (%)

0

72.2

38.5

< .01

Hypertension (%)

0

0

100

< .001

SBP (mmHg)

129.3 ± 21.4

134.3 ± 16.8

136.9 ± 20.2

0.66

DBP (mmHg)

74.8 ± 9.1

81.8 ± 9.2

79.3 ± 15.8

0.35

RF (0/1/2/3)

9/0/0/0

0/14/4/0

0/2/4/7

< .001

LVEDV (ml)

123.8 ± 26.4

121.9 ± 35.1

129.5 ± 29.6

0.80

LVESV (ml)

45.8 ± 13.4

39.3 ± 16.1

41.1 ± 12.8

0.55

EF (%)

63.1 ± 6.0

68.3 ± 6.2

68.4 ± 5.1

0.07

LVM (g)

99.9 ± 23.3

112.6 ± 31.3

127.8 ± 35.1

0.11

Native T1

ShMOLLI (ms)

1177.7 ± 28.6

1166.8 ± 24.3

1178.7 ± 51.7

0.70

MOLLI 5(3)3 (ms)

1207.9 ± 18.2

1197.0 ± 20.9

1206.8 ± 39.0

0.51

SASHA (ms)

1486.0 ± 24.1

1479.8 ± 29.6

1496.9 ± 48.9

0.44

  1. FH family history, CVD cardiovascular disease, SBP systolic blood pressure, DBP diastolic blood pressure, RF risk factors, LVEDV left-ventricular end-diastolic volume, LVESV left-ventricular end-systolic volume, EF ejection fraction, LVM left-ventricular mass, Sig significance